Cited by 353

Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics

Schulz, Martin, Schmoldt, Achim, Andresen-Streichert, Hilke, Iwersen-Bergmann, Stefanie·2020·Critical Care

Abstract

In order to assess the significance of drug/substance levels measured in intensive care medicine and clinical and forensic toxicology as well as for therapeutic drug monitoring, it is essential that a comprehensive collection of data is readily available. We revisited and expanded our 2012 compilation of therapeutic and toxic plasma concentration ranges as well as half-lives of now more than 1100 drugs and other xenobiotics. Data have been abstracted from original papers, text books, and previous compilations and have been completed with data collected in our own forensic and clinical toxicology laboratories. We compiled the data presented in the table and the corresponding annotations over the past 30+ years. A previous compilation was completely double-checked, revised, and updated, if necessary. In addition, more than 200 substances, especially drugs who have been introduced since 2012 to the market as well as illegal drugs and other xenobiotics which became known to cause intoxications were added. We carefully referenced all data. Moreover, the annotations providing details were updated and revised, when necessary. For more than 1100 drugs and other xenobiotics, therapeutic (“normal”) and, if data was available, toxic, and comatose-fatal plasma/blood concentrations as well as elimination half-lives were compiled in a table. In case of intoxications, the blood concentration of the substance and/or metabolite better predicts the clinical severity of the case when compared to the assumed amount and time of ingestion. Comparing and contrasting the clinical case against the data provided, including the half-life, may support the decision for or against further intensive care. In addition, the data provided are useful for the therapeutic monitoring of pharmacotherapies, to facilitate the diagnostic assessment and monitoring of acute and chronic intoxications as well as to support forensic and clinical expert opinions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13054-020-02915-5

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 18

  1. [1]McCarthy M Drug overdose has become leading cause of death from injury in US Brit Med J 2015 350 h3328 10.1136/bmj.h3328 26101223 · DOI
  2. [4]Schulz M Iwersen-Bergmann S Andresen H Schmoldt A Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics Crit Care 2012 16 R136 10.1186/cc11441 22835221 PMC3580721 · DOI
  3. [6]Launiainen T Ojanperä I Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma Drug Test Anal. 2014 6 4 308 316 10.1002/dta.1507 23881890 PMC4237191 · DOI
  4. [7]Druid H Holmgren P A compilation of fatal and control concentrations of drugs in postmortem femoral blood J Forensic Sci 1997 42 79 87 10.1520/JFS14071J 8988577 · DOI
  5. [9]Hiemke C Bergemann N Clement HW Conca A Deckert J Domschke K Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017 Pharmacopsychiatry. 2018 51 1/02 9 62 10.1055/s-0043-116492 28910830 · DOI
  6. [10]Meyer FP Indicative therapeutic and toxic drug concentrations in plasma: a tabulation Int J Clin Pharmacol Ther 1994 32 2 71 81 8004362
  7. [11]Moffat AC Jackson JV Moss MS Widdop B Clarke’s isolation and identification of drugs in pharmaceuticals, body fluids, and post-mortem material 1986 2 London Pharmaceutical Press
  8. [12]Ketola RA Ojanperä I Summary statistics for drug concentrations in post-mortem femoral blood representing all causes of death Drug Test Anal 2019 11 9 1326 1337 10.1002/dta.2655 31128576 · DOI
  9. [13]Repetto MR Repetto M Therapeutic, toxic, and lethal concentrations in human fluids of 90 drugs affecting the cardiovascular and hematopoietic systems J Toxicol Clin Toxicol 1997 35 4 345 351 10.3109/15563659709043365 9204093 · DOI
  10. [14]Repetto MR Repetto M Habitual, toxic, and lethal concentrations of 103 drugs of abuse in humans J Toxicol Clin Toxicol 1997 35 1 1 9 10.3109/15563659709001158 9022645 · DOI
  11. [15]Repetto MR Repetto M Therapeutic, toxic, and lethal concentrations of 73 drugs affecting respiratory system in human fluids J Toxicol Clin Toxicol 1998 36 4 287 293 10.3109/15563659809028023 9711193 · DOI
  12. [16]Repetto MR Repetto M Concentrations in human fluids: 101 drugs affecting the digestive system and metabolism J Toxicol Clin Toxicol 1999 37 1 1 9 10.1081/CLT-100102401 10078153 · DOI
  13. [17]Stead AH Moffat AC A collection of therapeutic, toxic and fatal blood drug concentrations in man Hum Toxicol 1983 2 3 437 464 10.1177/096032718300200301 6885090 · DOI
  14. [20]Neels HM Sierens AC Naelaerts K Scharpe SL Hatfield GM Lambert WE Therapeutic drug monitoring of old and newer anti-epileptic drugs Clin Chem Lab Med 2004 42 11 1228 1255 10.1515/CCLM.2004.245 15576287 · DOI
  15. [21]Regenthal R Krueger M Koeppel C Preiss R Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs J Clin Monit Comput 1999 15 7–8 529 544 10.1023/A:1009935116877 12578052 · DOI
  16. [22]Winek CL Wahba WW Winek CL Jr Balzer TW Drug and chemical blood-level data 2001 Forensic Sci Int 2001 122 2–3 107 123 10.1016/S0379-0738(01)00483-2 11672964 · DOI
  17. [23]Musshoff F Padosch S Steinborn S Madea B Fatal blood and tissue concentrations of more than 200 drugs Forensic Sci Int 2004 142 2–3 161 210 10.1016/j.forsciint.2004.02.017 15172079 · DOI
  18. [25]Sutherland JJ Morrison RD McNaughton CD Daly TM Milne SB Daniels JS Assessment of patient medication adherence, medical record accuracy, and medication blood concentrations for prescription and over-the-counter medications (Supplementary Online Content eTable 2) JAMA Netw Open 2018 1 7 e184196 10.1001/jamanetworkopen.2018.4196 30646345 PMC6324396 · DOI

Cited by

Sorted by citations

Authors
Schulz, M., Schmoldt, A., Andresen-Streichert, H., & Iwersen-Bergmann, S.
Venue
Critical Care
Published
2020-05-06
Volume
24
Issue
1
ISSN
1364-8535
Cited by
353
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review